Global Octreotide Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Octreotide Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

Octreotide is an octapeptide that mimics natural somatostatin pharmacologically,it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.

According to APO Research, The global Octreotide market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Octreotide is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Octreotide include Novartis, Sun Pharmaceutical, Chengdu Tiantaishan pharmaceutical, Sinopharm A-Think Pharmaceuticals, Sihuan Pharmaceutical Holdings Group, Shanghai Soho-Yiming Pharmaceuticals and Yibin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Octreotide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Octreotide, also provides the sales of main regions and countries. Of the upcoming market potential for Octreotide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Octreotide sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Octreotide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Octreotide sales, projected growth trends, production technology, application and end-user industry.

Octreotide segment by Company

Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Octreotide segment by Type

Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Octreotide segment by Application

Treating Severe Diarrhea
Treating Acromegaly
Others
Octreotide segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Octreotide status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Octreotide market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Octreotide significant trends, drivers, influence factors in global and regions.
6. To analyze Octreotide competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Octreotide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Octreotide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Octreotide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Octreotide market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Octreotide industry.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Octreotide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Octreotide in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Octreotide Sales Value (2019-2030)
1.2.2 Global Octreotide Sales Volume (2019-2030)
1.2.3 Global Octreotide Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Octreotide Market Dynamics
2.1 Octreotide Industry Trends
2.2 Octreotide Industry Drivers
2.3 Octreotide Industry Opportunities and Challenges
2.4 Octreotide Industry Restraints
3 Octreotide Market by Company
3.1 Global Octreotide Company Revenue Ranking in 2023
3.2 Global Octreotide Revenue by Company (2019-2024)
3.3 Global Octreotide Sales Volume by Company (2019-2024)
3.4 Global Octreotide Average Price by Company (2019-2024)
3.5 Global Octreotide Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Octreotide Company Manufacturing Base & Headquarters
3.7 Global Octreotide Company, Product Type & Application
3.8 Global Octreotide Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Octreotide Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Octreotide Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Octreotide Market by Type
4.1 Octreotide Type Introduction
4.1.1 Octreotide Injection
4.1.2 Octreotide Powder
4.1.3 Octreotide Microspheres
4.2 Global Octreotide Sales Volume by Type
4.2.1 Global Octreotide Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Octreotide Sales Volume by Type (2019-2030)
4.2.3 Global Octreotide Sales Volume Share by Type (2019-2030)
4.3 Global Octreotide Sales Value by Type
4.3.1 Global Octreotide Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Octreotide Sales Value by Type (2019-2030)
4.3.3 Global Octreotide Sales Value Share by Type (2019-2030)
5 Octreotide Market by Application
5.1 Octreotide Application Introduction
5.1.1 Treating Severe Diarrhea
5.1.2 Treating Acromegaly
5.1.3 Others
5.2 Global Octreotide Sales Volume by Application
5.2.1 Global Octreotide Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Octreotide Sales Volume by Application (2019-2030)
5.2.3 Global Octreotide Sales Volume Share by Application (2019-2030)
5.3 Global Octreotide Sales Value by Application
5.3.1 Global Octreotide Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Octreotide Sales Value by Application (2019-2030)
5.3.3 Global Octreotide Sales Value Share by Application (2019-2030)
6 Octreotide Market by Region
6.1 Global Octreotide Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Octreotide Sales by Region (2019-2030)
6.2.1 Global Octreotide Sales by Region: 2019-2024
6.2.2 Global Octreotide Sales by Region (2025-2030)
6.3 Global Octreotide Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Octreotide Sales Value by Region (2019-2030)
6.4.1 Global Octreotide Sales Value by Region: 2019-2024
6.4.2 Global Octreotide Sales Value by Region (2025-2030)
6.5 Global Octreotide Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Octreotide Sales Value (2019-2030)
6.6.2 North America Octreotide Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Octreotide Sales Value (2019-2030)
6.7.2 Europe Octreotide Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Octreotide Sales Value (2019-2030)
6.8.2 Asia-Pacific Octreotide Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Octreotide Sales Value (2019-2030)
6.9.2 Latin America Octreotide Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Octreotide Sales Value (2019-2030)
6.10.2 Middle East & Africa Octreotide Sales Value Share by Country, 2023 VS 2030
7 Octreotide Market by Country
7.1 Global Octreotide Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Octreotide Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Octreotide Sales by Country (2019-2030)
7.3.1 Global Octreotide Sales by Country (2019-2024)
7.3.2 Global Octreotide Sales by Country (2025-2030)
7.4 Global Octreotide Sales Value by Country (2019-2030)
7.4.1 Global Octreotide Sales Value by Country (2019-2024)
7.4.2 Global Octreotide Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.5.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.6.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.7.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.8.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.9.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.10.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.11.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.12.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.13.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.14.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.15.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.16.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.17.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.18.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.19.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.20.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.21.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.22.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Octreotide Sales Value Growth Rate (2019-2030)
7.23.2 Global Octreotide Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Octreotide Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Novartis
8.1.1 Novartis Comapny Information
8.1.2 Novartis Business Overview
8.1.3 Novartis Octreotide Sales, Value and Gross Margin (2019-2024)
8.1.4 Novartis Octreotide Product Portfolio
8.1.5 Novartis Recent Developments
8.2 Sun Pharmaceutical
8.2.1 Sun Pharmaceutical Comapny Information
8.2.2 Sun Pharmaceutical Business Overview
8.2.3 Sun Pharmaceutical Octreotide Sales, Value and Gross Margin (2019-2024)
8.2.4 Sun Pharmaceutical Octreotide Product Portfolio
8.2.5 Sun Pharmaceutical Recent Developments
8.3 Chengdu Tiantaishan pharmaceutical
8.3.1 Chengdu Tiantaishan pharmaceutical Comapny Information
8.3.2 Chengdu Tiantaishan pharmaceutical Business Overview
8.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Value and Gross Margin (2019-2024)
8.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
8.3.5 Chengdu Tiantaishan pharmaceutical Recent Developments
8.4 Sinopharm A-Think Pharmaceuticals
8.4.1 Sinopharm A-Think Pharmaceuticals Comapny Information
8.4.2 Sinopharm A-Think Pharmaceuticals Business Overview
8.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Value and Gross Margin (2019-2024)
8.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
8.4.5 Sinopharm A-Think Pharmaceuticals Recent Developments
8.5 Sihuan Pharmaceutical Holdings Group
8.5.1 Sihuan Pharmaceutical Holdings Group Comapny Information
8.5.2 Sihuan Pharmaceutical Holdings Group Business Overview
8.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Value and Gross Margin (2019-2024)
8.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
8.5.5 Sihuan Pharmaceutical Holdings Group Recent Developments
8.6 Shanghai Soho-Yiming Pharmaceuticals
8.6.1 Shanghai Soho-Yiming Pharmaceuticals Comapny Information
8.6.2 Shanghai Soho-Yiming Pharmaceuticals Business Overview
8.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Value and Gross Margin (2019-2024)
8.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
8.6.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments
8.7 Yibin Pharmaceutical
8.7.1 Yibin Pharmaceutical Comapny Information
8.7.2 Yibin Pharmaceutical Business Overview
8.7.3 Yibin Pharmaceutical Octreotide Sales, Value and Gross Margin (2019-2024)
8.7.4 Yibin Pharmaceutical Octreotide Product Portfolio
8.7.5 Yibin Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Octreotide Value Chain Analysis
9.1.1 Octreotide Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Octreotide Sales Mode & Process
9.2 Octreotide Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Octreotide Distributors
9.2.3 Octreotide Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings